Detailed information for compound 165309

Basic information

Technical information
  • TDR Targets ID: 165309
  • Name: 2-cyclohexyl-4,6-dipropyltriazolo[4,5-d]pyrim idine-5,7-dione
  • MW: 319.402 | Formula: C16H25N5O2
  • H donors: 0 H acceptors: 4 LogP: 3.3 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCn1c2nn(nc2c(=O)n(c1=O)CCC)C1CCCCC1
  • InChi: 1S/C16H25N5O2/c1-3-10-19-14-13(15(22)20(11-4-2)16(19)23)17-21(18-14)12-8-6-5-7-9-12/h12H,3-11H2,1-2H3
  • InChiKey: PQVUCZDOKIHEBD-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-cyclohexyl-4,6-dipropyl-triazolo[4,5-d]pyrimidine-5,7-dione
  • 2-cyclohexyl-4,6-dipropyl-[1,2,3]triazolo[4,5-d]pyrimidine-5,7-dione
  • 2-cyclohexyl-4,6-dipropyl-triazolo[4,5-d]pyrimidine-5,7-quinone
  • 2-cyclohexyl-4,6-dipropyltriazolo[4,5-e]pyrimidine-5,7-dione
  • 2-cyclohexyl-4,6-dipropyl-triazolo[4,5-e]pyrimidine-5,7-dione
  • 2-cyclohexyl-4,6-dipropyl-triazolo[4,5-e]pyrimidine-5,7-quinone
  • 2-cyclohexyl-4,6-dipropyl-[1,2,3]triazolo[4,5-e]pyrimidine-5,7-dione

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Bos taurus Adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) neuropeptide F receptor Adenosine A1 receptor   326 aa 316 aa 19.3 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 307 aa 21.2 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Adenosine A1 receptor   326 aa 331 aa 25.7 %
Schistosoma mansoni opsin-like receptor Adenosine A1 receptor   326 aa 315 aa 23.8 %
Schistosoma mansoni opsin-like receptor Adenosine A1 receptor   326 aa 312 aa 22.1 %
Echinococcus granulosus allatostatin A receptor Adenosine A1 receptor   326 aa 304 aa 25.3 %
Echinococcus multilocularis allatostatin A receptor Adenosine A1 receptor   326 aa 306 aa 26.1 %
Schistosoma japonicum 5-hydroxytryptamine receptor 4, putative Adenosine A1 receptor   326 aa 301 aa 25.6 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 314 aa 21.7 %
Brugia malayi hypothetical protein Adenosine A1 receptor   326 aa 311 aa 21.9 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 311 aa 21.9 %
Loa Loa (eye worm) hypothetical protein Adenosine A1 receptor   326 aa 296 aa 22.6 %
Onchocerca volvulus Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog Adenosine A1 receptor   326 aa 286 aa 22.7 %
Schistosoma mansoni peptide (allatostatin)-like receptor Adenosine A1 receptor   326 aa 312 aa 24.0 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 277 aa 23.8 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 326 aa 20.2 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A1 receptor   326 aa 318 aa 22.3 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0081 0.0119 0.0119
Loa Loa (eye worm) hypothetical protein 0.1509 0.6739 0.6739
Trypanosoma brucei hexokinase 0.2213 1 0.5
Echinococcus granulosus hexokinase type 2 0.2213 1 1
Entamoeba histolytica hexokinase 1 0.2213 1 0.5
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.028 0.104 0.104
Loa Loa (eye worm) hypothetical protein 0.0081 0.0119 0.0119
Brugia malayi hexokinase type II 0.0703 0.3004 0.3004
Plasmodium vivax hexokinase, putative 0.2213 1 0.5
Echinococcus multilocularis hexokinase 0.2213 1 1
Brugia malayi Hexokinase family protein 0.2213 1 1
Brugia malayi Hexokinase family protein 0.1388 0.6178 0.6178
Trypanosoma cruzi hexokinase, putative 0.2213 1 0.5
Plasmodium falciparum hexokinase 0.2213 1 0.5
Echinococcus granulosus potassium voltage gated channel subfamily H 0.028 0.104 0.104
Schistosoma mansoni voltage-gated potassium channel 0.0081 0.0119 0.0119
Treponema pallidum hexokinase (hxk) 0.2213 1 0.5
Echinococcus multilocularis voltage gated potassium channel 0.0081 0.0119 0.0119
Trypanosoma brucei hexokinase 0.2213 1 0.5
Echinococcus multilocularis hexokinase type 2 0.2213 1 1
Echinococcus granulosus voltage gated potassium channel 0.0081 0.0119 0.0119
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.028 0.104 0.104
Echinococcus multilocularis hexokinase 0.2213 1 1
Leishmania major hexokinase, putative 0.2213 1 0.5
Onchocerca volvulus 0.2213 1 1
Loa Loa (eye worm) hypothetical protein 0.0243 0.0869 0.0869
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0081 0.0119 0.0119
Schistosoma mansoni hexokinase 0.2213 1 1
Leishmania major hexokinase, putative 0.2213 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0703 0.3004 0.3004
Loa Loa (eye worm) hexokinase 0.2213 1 1
Echinococcus multilocularis hexokinase 0.2213 1 1
Loa Loa (eye worm) hypothetical protein 0.0703 0.3004 0.3004
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.028 0.104 0.104
Loa Loa (eye worm) hexokinase 0.2213 1 1
Loa Loa (eye worm) hexokinase 0.0685 0.2917 0.2917
Schistosoma mansoni voltage-gated potassium channel 0.0306 0.116 0.116
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.0081 0.0119 0.0119
Loa Loa (eye worm) hexokinase type II 0.2213 1 1
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0261 0.0955 1
Schistosoma mansoni voltage-gated potassium channel 0.0081 0.0119 0.0119
Schistosoma mansoni voltage-gated potassium channel 0.0306 0.116 0.116
Toxoplasma gondii hexokinase 0.2213 1 0.5
Onchocerca volvulus 0.2213 1 1
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0261 0.0955 1
Echinococcus granulosus hexokinase 0.2213 1 1
Echinococcus granulosus hexokinase 0.2213 1 1
Entamoeba histolytica hexokinase 2 0.2213 1 0.5
Trypanosoma brucei hexokinase, putative 0.2213 1 0.5
Onchocerca volvulus 0.2213 1 1
Brugia malayi Hexokinase family protein 0.0685 0.2917 0.2917
Loa Loa (eye worm) hexokinase 0.1388 0.6178 0.6178
Trypanosoma cruzi hexokinase, putative 0.2213 1 0.5
Echinococcus granulosus hexokinase 0.2213 1 1

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 1.6 uM Affinity to A1 adenosine receptor was measured by the displacement of [3H]-PIA in bovine brain cortical membrane ChEMBL. 8071944
Ki (binding) = 1.6 uM Affinity to A1 adenosine receptor was measured by the displacement of [3H]-PIA in bovine brain cortical membrane ChEMBL. 8071944
Ki (binding) = 21.7 uM Affinity to A2 adenosine receptor was measured by the displacement of [3H]-CGS- 21680 in bovine brain striatal membrane ChEMBL. 8071944
Ki (binding) = 21.7 uM Affinity to A2 adenosine receptor was measured by the displacement of [3H]-CGS- 21680 in bovine brain striatal membrane ChEMBL. 8071944
Ratio (binding) = 13 Ratio between the Ki values of A2 and A1 receptors ChEMBL. 8071944

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.